Following this activity, participants should be able to: (1) Describe the role of maintenance therapy in the management of acute myeloid leukemia (AML). (2) Identify targeted therapies and describe their corresponding clinical settings for maintenance therapy in the management of AML. (3) Discuss prominent patient counseling points on agents used for maintenance therapy in AML.
- Provider:National Comprehensive Cancer Network
- Activity Link: https://education.nccn.org/node/96107
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Exelixis - Amount: 0.0 - Is Kind Support: False Source: GlaxoSmithKline - Amount: 0.0 - Is Kind Support: False Source: Menarini-Stemline - Amount: 0.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0.0 - Is Kind Support: False Source: Regeneron Pharmaceuticals, Inc. - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest